Six Drugs Added to Knowledgebase

We added six new drugs to the knowledgebase:

• Glofitamab is a bispecific antibody for the treatment of Diffuse Large B-Cell Lymphoma is being developed by Roche
• Serplulimab is a PD-1 checkpoint inhibitor for the treatment of Extensive-stage small-cell lung cancer is being developed by Henlius
• Sabizabulin is a microtubule disruptor for the treatment of Metastatic castration-resistant prostate cancer, COVID-19 is being developed by Veru
• Cosibelimab is a PD-1 checkpoint inhibitor for the treatment of Cutaneous squamous cell carcinoma is being developed by Checkpoint Therapeutics
• Stannous protoporphyrin, Iron sucrose is a protoporphyrin and pro-oxidant combination for the treatment of Reduce cardiac surgery complications is being developed by Renibus Therapeutics
• Exagamglogene autotemcel (exa-cel) is a CRISPR gene-edited autologous hematopoietic stem cell therapy for the treatment of Transfusion-dependent beta-thalassemia is being developed by Vertex Pharmaceuticals​
  

The Prescribe Right Pharmaceutical Pipeline Tracker now allows you to track 1,047 pipeline and recently approved drugs supported by 2,663 announced and published study results.